series-c-plus
Stage
2
Investors
About
Maze Therapeutics is a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with kidney and metabolic diseases, leveraging genetic insights to create novel therapies.
Explore Maze Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.